Open access
Five‐Year Survival Analyses on Non‐Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real‐World Cohort Study
Wei-Bin Liu
Yu-Jie Deng
Yang-Chih Lin
Yi-Jin Lin
Xue-Jing Zheng
Wei-Kun Su
Wei-Jin Xiao
Yi Shi
Jia-Rong Zhang
Xiao-Hui Chen
Medicine
Abstract
Non‐pathological complete response (non‐pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long‐term outcomes and postoperative risk stratification in the immunotherapy era remains limited.